Wearable Injectors Market to Witness an Outstanding Growth by 2021-2031 | Ypsomed, Amgen, Subcuject, Enable Injections, Medtronic plc

The global wearable injectors market was valued at USD 5.3 billion in 2021 and it is anticipated to grow up to USD 21.7 billion by 2031, at a CAGR of 13.3% during the forecast period.

New York, According to a new market research report published by Global Insight Services Wearable Injectors Market is expected to reach US$ XX bn by 2031. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Drug delivery systems known as wearable injectors attach to the body and automatically administer patients' prescribed doses at the right moment. Wearable injectors, in contrast to insulin pumps, is a one-time use devices that are comfortably worn on the body while the medication is subcutaneously injected over a pre-programmed period of seconds or hours. They are taken out of the body and conveniently disposed after the entire dose has been injected. The concept of patient centricity and a greater emphasis on human factors in drug delivery design have encouraged the development of such devices.

Read more about Wearable Injectors Market here : https://www.globalinsightservices.com/reports/wearable-injectors-market

Market Trends and Drivers

A growing emphasis on the use of biologics and monoclonal antibodies (mAbs) to treat diseases such as rheumatoid arthritis, cardiovascular disease, and cancer will provide significant growth opportunities for wearable injectors, as these drugs must be administered parenterally (intravenous, subcutaneous, or intramuscular delivery). According to PhRMA (Pharmaceutical Research and Manufacturers of America), 907 biologics were in development in 2013; the number of biologic drugs in development is continuing to grow exponentially, with over 2,700 remedies in development as of mid-2017, more than tripling the 907 in development in 2013. mAb-based biotherapies account for half of the top 100 drugs and are expected to continue to dominate the pharmaceutical market.

Market Restraints and Challenges

Wearable injectors are not reimbursed in a number of developing countries. In India, for example, wearable insulin pumps are not reimbursed, and no specific guidelines for their use are provided on prescription. Patients with Type 1 diabetes in China must pay for insulin pumps and supplies out of pocket. The lack of reimbursement has a direct impact on access to and adoption of wearable injectors, and is thus expected to have a negative impact on market growth in the coming years.

Download a Free PDF Sample Copy of Report : https://www.globalinsightservices.com/request-sample/GIS10384

Global Wearable Injectors Market Segmental Overview

The report analyses the Global wearable injectors market based on type, technology, application, end-use, and region.

Global Wearable Injectors Market by Type

Based on type, it is segmented into the on-body and off-body. The on-body segment is likely to account for the significant market share during the forecast period. The key factors attributing the growth of the market is higher adoption rate of on-body wearable injectors coupled with the cost effectiveness. Moreover, with the help of on-body injectors patients ease to deliver a precise amount of drug to the body over a controlled period of time. and sensitivity to temperature variations with better patient access. Hence, the aforementioned factors will fuel segmental growth over the forecast period. Moreover, increasing advanced product launch by major market player fule the segmental growth. For instance, in 2019, Enable Injections formed a partnership with Sanofi for its enFuse drug delivery platform. enFuse is an on-body drug delivery platform that has a self-contained drug transfer system, which is compatible with standard syringes or vial container formats. Based on type, the market is segmented into on-body and off-body wearable injectors.

Major Players in the Global Wearable Injectors Market

The key players in the market are Ypsomed (Switzerland), Amgen (US), Subcuject (Denmark), Enable Injections (US), Medtronic plc (Ireland), Insulet Corporation (US), United Therapeutics Corp. (US), CeQur SA (Switzerland), Sensile Medical (Switzerland), ATS Automation (Canada), West Pharmaceutical Services, Inc. (US), Tandem Diabetes Care (US), Sonceboz (Switzerland), Noble (US), Elcam Drug Delivery Devices (Israel), Bespak Europe Ltd. (UK), Stevanato Group (Italy), Sorrel Medical (Israel), Weibel CDS AG (Switzerland), and Neuma (US) among others.

Get Customized report as per your requirements : https://www.globalinsightservices.com/request-customization/GIS10384

Reasons to buy Wearable Injectors Market Report:

• Develop comprehensive understanding of market landscape - industry structure, value-chain, key players, trends, drivers, and challenges
• Drive revenue and market-entry strategy by gaining insights into which segments and geographies are largest and likely to grow fastest
• Formulate sales and marketing strategies by gaining understanding of competitors, their positioning, and strengths & weaknesses
• Develop business and M&A strategies through understanding of latest trends and emerging players in the market
• Refine your business plans by understanding impact of disruptions such as Covid-19 and Russia-Ukraine conflict on the market

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.